Matches in Wikidata for { <http://www.wikidata.org/entity/Q92622951> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q92622951 description "article scientifique publié en 2019" @default.
- Q92622951 description "artículu científicu espublizáu en marzu de 2019" @default.
- Q92622951 description "im März 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92622951 description "scientific article published on 26 March 2019" @default.
- Q92622951 description "wetenschappelijk artikel" @default.
- Q92622951 description "наукова стаття, опублікована 26 березня 2019" @default.
- Q92622951 name "Advances in the use of PARP inhibitors for BRCA1/2-associated breast cancer: talazoparib" @default.
- Q92622951 name "Advances in the use of PARP inhibitors for BRCA1/2-associated breast cancer: talazoparib" @default.
- Q92622951 type Item @default.
- Q92622951 label "Advances in the use of PARP inhibitors for BRCA1/2-associated breast cancer: talazoparib" @default.
- Q92622951 label "Advances in the use of PARP inhibitors for BRCA1/2-associated breast cancer: talazoparib" @default.
- Q92622951 prefLabel "Advances in the use of PARP inhibitors for BRCA1/2-associated breast cancer: talazoparib" @default.
- Q92622951 prefLabel "Advances in the use of PARP inhibitors for BRCA1/2-associated breast cancer: talazoparib" @default.
- Q92622951 P1433 Q92622951-34CFD445-C43C-43E6-8183-FBADF780DF5F @default.
- Q92622951 P1476 Q92622951-8CF25E16-E644-448A-BAE2-78678BF25EB6 @default.
- Q92622951 P2093 Q92622951-5AD04200-B8FD-4E11-B94B-5488A68601A3 @default.
- Q92622951 P304 Q92622951-601C12EF-3B16-4AB6-9E4F-29C460D89DAE @default.
- Q92622951 P31 Q92622951-BB125FC7-6735-4239-9496-4EB3FAA22853 @default.
- Q92622951 P356 Q92622951-7F8D9AAF-2D6C-4634-9C3C-AB55A4DD223E @default.
- Q92622951 P433 Q92622951-BF2ECC28-00E1-48AD-B2E7-0CD3B34246C5 @default.
- Q92622951 P478 Q92622951-4FCF80A4-87E3-4588-AD55-98A92F3B12EF @default.
- Q92622951 P577 Q92622951-D34D6D01-ABC5-449B-90E5-50C167707005 @default.
- Q92622951 P698 Q92622951-B9693F76-EF57-4847-A7C7-F980A9D2C8F8 @default.
- Q92622951 P356 FON-2018-0751 @default.
- Q92622951 P698 30912451 @default.
- Q92622951 P1433 Q2781597 @default.
- Q92622951 P1476 "Advances in the use of PARP inhibitors for BRCA1/2-associated breast cancer: talazoparib" @default.
- Q92622951 P2093 "Kelly E McCann" @default.
- Q92622951 P304 "1707-1715" @default.
- Q92622951 P31 Q13442814 @default.
- Q92622951 P356 "10.2217/FON-2018-0751" @default.
- Q92622951 P433 "15" @default.
- Q92622951 P478 "15" @default.
- Q92622951 P577 "2019-03-26T00:00:00Z" @default.
- Q92622951 P698 "30912451" @default.